Semaglutide Tablets
(Oral GLP‑1)
Needle‑free GLP‑1 confidence—daily tablet routine with clinician guidance.
What it is
Semaglutide, the active ingredient in brand names such as Ozempic, Wegovy, and Rybelsus, offers significant health benefits primarily related to the management of type 2 diabetes, chronic weight management, and the reduction of major cardiovascular and chronic kidney disease risks.
The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The FDA does not review or approve any compounded medications for safety or effectiveness. Off-label use must be prescribed and supervised by a licensed provider.
Why patients pick tablets
Zero needles
Same GLP‑1 class—simplified daily routine.
Appetite under control
Helps you feel satisfied on less, so wins stack up.
Personalized timing
Your clinician tunes dose and schedule around your day.
Primary Benefits
Improved Glycemic Control
Semaglutide helps adults with type 2 diabetes manage their blood sugar levels by stimulating insulin production and reducing the amount of glucose released by the liver.
Significant Weight Loss
It is an effective treatment for chronic weight management in people with obesity or who are overweight with a related health condition (e.g., high blood pressure, type 2 diabetes, high cholesterol). This occurs by slowing gastric emptying and targeting brain areas that regulate appetite, leading to increased feelings of fullness and reduced hunger and cravings.
Reduced Cardiovascular Risk
In patients with type 2 diabetes or those with obesity/overweight and established heart disease, semaglutide significantly lowers the risk of major adverse cardiovascular events such as heart attack, stroke, or cardiovascular death.
Improved Kidney Function
It is approved to reduce the risk of kidney function decline, kidney failure, and death from cardiovascular causes in adults with type 2 diabetes and chronic kidney disease.
- How It Works
- How It Works
- How It Works
- How It Works
- How It Works
Smart questionnaire.
Asynchronous clinician review.
If approved, discreet U.S. pharmacy delivery.
Potential and Emerging Benefits
Beyond its primary approved uses, ongoing research is exploring other potential benefits:
Anti-inflammatory Effects
Semaglutide has shown anti-inflammatory properties that may benefit the cardiovascular system, liver, and kidneys by reducing inflammatory markers and modulating immune system activity.
Improved Mental Health
Some patients report lower levels of anxiety and depression and improved self-esteem as a result of achieving weight loss and better health control.
Polycystic Ovary Syndrome (PCOS)
Early studies suggest it may help manage PCOS symptoms by improving insulin sensitivity, promoting weight loss, and normalizing menstrual cycles.
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Semaglutide has received accelerated FDA approval for the treatment of MASH (formerly known as NASH) in adults with moderate to advanced liver fibrosis.
Neurological Conditions
Researchers are investigating its potential to slow cognitive decline in early Alzheimer's disease due to its neuroprotective and anti-inflammatory properties.
Semaglutide is a prescription medication and should be used under the guidance of a healthcare professional, alongside a reduced-calorie diet and increased physical activity, to ensure safety and effectiveness.
Compare vs Competitors
| Name | Details |
|---|---|
| RO Body | $45 first month → $145/mo membership (medication extra). |
| Hims | Oral kits from $69/mo with 10‑month prepay; GLP‑1 plans from $199/mo with 6‑month prepay. |
| Eden | GLP‑1 plans $139 first month then $239/mo. |
You have questions ? Get answers
Positive, Proof‑backed
Dose and population matter; injections often achieve higher averages, but tablets are a practical, needle‑free path for many adults. Your clinician will help you choose.
*Results vary; your plan is individualized.
Disclaimer: Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. The FDA does not review or approve any compounded medications for safety or effectiveness. These treatments are individualized and do not guarantee specific results. Provider-determined, off-label use may apply.